Nandini Matiyani has been appointed as the new Executive Vice President, Human Resources at Strides Pharma Science Ltd, marking an important addition to the company’s leadership team. With Strides’ purpose-driven approach, global footprint, and strong people-centric values, Nandini steps into this role fully aligned with the organization’s vision and energized to contribute to its next phase of growth.
Over the past two decades, Nandini Matiyani has built a distinguished career shaping people strategy across multinational enterprises and publicly listed technology organizations. She has held impactful HR leadership roles at RateGain, Wipro, and OnMobile Global Limited, where she partnered closely with CEOs, Boards, and CXO teams to align human capital with business priorities. Her experience in navigating global, matrixed structures has strengthened her ability to build organizational capability and nurture high-performance cultures.
Throughout her career, Nandini Matiyani has led large-scale transformation initiatives, driven leadership succession and strategic talent programs, championed DE&I, and enabled culture-building through values-driven change. As a Certified PAPI™️ Facilitator and Six Sigma Black Belt, she combines human-centered leadership with process excellence—bringing both empathy and operational rigor to every mandate.
At her core, Nandini Matiyani is a trusted advisor and strategic partner to leadership, focused on creating environments where people grow, cultures evolve, and organizations scale with purpose. Her experience and people-first philosophy strongly resonate with Strides Pharma Science Ltd, a global pharmaceutical company present in over 100 countries with the purpose of delivering trusted medicines that improve lives and transform health.
As she takes on her new role at Strides, Nandini Matiyani looks forward to working closely with teams across geographies to strengthen capabilities, reinforce culture, and contribute to Strides’ ambition to make better and fairer heathcare a reality – through agility, care and meaningful innovation that delivers quality and lasting value for patients, partners and shareholders.